ascopubs.org

Comparative outcomes of patients with intraductal papillary mucinous neoplasm associated cancer (IPMN-Ca) to those with pancreatic ductal carcinoma (PDAC) following resection.

Interim analysis of a phase II study of dose-modified FOLFIRINOX (mFOLFIRINOX) in locally advanced (LAPC) and metastatic pancreatic cancer (MPC).